Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapy ; volume:14 ; number:1 ; day:9 ; month:11 ; year:2023 ; pages:1-18 ; date:12.2023
Nature Communications ; 14, Heft 1 (9.11.2023), 1-18, 12.2023
- Creator
-
Wang, Zhiren
Li, Wenpan
Jiang, Yanhao
Tran, Tuyen Ba
Cordova, Leyla Estrella
Chung, Jinha
Kim, Minhyeok
Wondrak, Georg
Erdrich, Jennifer
Lu, Jianqin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-023-43079-4
- URN
-
urn:nbn:de:101:1-2024012911391096345667
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Zhiren
- Li, Wenpan
- Jiang, Yanhao
- Tran, Tuyen Ba
- Cordova, Leyla Estrella
- Chung, Jinha
- Kim, Minhyeok
- Wondrak, Georg
- Erdrich, Jennifer
- Lu, Jianqin
- SpringerLink (Online service)
Other Objects (12)
Genetically Engineered‐Cell‐Membrane Nanovesicles for Cancer Immunotherapy
HB‐EGF‐loaded nanovesicles enhance trophectodermal spheroid attachment and invasion
Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapy
Tea polyphenol-engineered hybrid cellular nanovesicles for cancer immunotherapy and androgen deprivation therapy
Author Correction: Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapy
Allogeneic “Zombie Cell” as Off‐The‐Shelf Vaccine for Postsurgical Cancer Immunotherapy
Triple‐Combination Immunogenic Nanovesicles Reshape the Tumor Microenvironment to Potentiate Chemo‐Immunotherapy in Preclinical Cancer Models
Leveraging epigenetics to enhance the efficacy of immunotherapy
The postsurgical pancreas
Targeted Delivery of PD‐L1‐Derived Phosphorylation‐Mimicking Peptides by Engineered Biomimetic Nanovesicles to Enhance Osteosarcoma Treatment
Bacterial protoplast-derived nanovesicles carrying CRISPR-Cas9 tools re-educate tumor-associated macrophages for enhanced cancer immunotherapy
Zur enzymatischen Analytik des HDL-Sphingomyelin
Genetically Engineered‐Cell‐Membrane Nanovesicles for Cancer Immunotherapy
HB‐EGF‐loaded nanovesicles enhance trophectodermal spheroid attachment and invasion
Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapy
Tea polyphenol-engineered hybrid cellular nanovesicles for cancer immunotherapy and androgen deprivation therapy
Author Correction: Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapy
Allogeneic “Zombie Cell” as Off‐The‐Shelf Vaccine for Postsurgical Cancer Immunotherapy
Triple‐Combination Immunogenic Nanovesicles Reshape the Tumor Microenvironment to Potentiate Chemo‐Immunotherapy in Preclinical Cancer Models
Leveraging epigenetics to enhance the efficacy of immunotherapy
The postsurgical pancreas
Targeted Delivery of PD‐L1‐Derived Phosphorylation‐Mimicking Peptides by Engineered Biomimetic Nanovesicles to Enhance Osteosarcoma Treatment
Bacterial protoplast-derived nanovesicles carrying CRISPR-Cas9 tools re-educate tumor-associated macrophages for enhanced cancer immunotherapy
Zur enzymatischen Analytik des HDL-Sphingomyelin
Genetically Engineered‐Cell‐Membrane Nanovesicles for Cancer Immunotherapy
HB‐EGF‐loaded nanovesicles enhance trophectodermal spheroid attachment and invasion
Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapy
Tea polyphenol-engineered hybrid cellular nanovesicles for cancer immunotherapy and androgen deprivation therapy
Author Correction: Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapy
Allogeneic “Zombie Cell” as Off‐The‐Shelf Vaccine for Postsurgical Cancer Immunotherapy
Triple‐Combination Immunogenic Nanovesicles Reshape the Tumor Microenvironment to Potentiate Chemo‐Immunotherapy in Preclinical Cancer Models
Leveraging epigenetics to enhance the efficacy of immunotherapy
The postsurgical pancreas
Targeted Delivery of PD‐L1‐Derived Phosphorylation‐Mimicking Peptides by Engineered Biomimetic Nanovesicles to Enhance Osteosarcoma Treatment
Bacterial protoplast-derived nanovesicles carrying CRISPR-Cas9 tools re-educate tumor-associated macrophages for enhanced cancer immunotherapy